EdgarLookup

NRX Pharmaceuticals, Inc. — PRE 14A Filings

11 PRE 14A filings on record

This page lists all PRE 14A filings submitted to the SEC by NRX Pharmaceuticals, Inc. (NRXPW), sorted by most recent first. Each row links to the full filing on EdgarLookup. NRX Pharmaceuticals, Inc. has filed 11 PRE 14A documents with the SEC since 2017. To view all SEC filings by NRX Pharmaceuticals, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 25-NSE 3 4 4/A 424B3 424B4 424B5 424B7 425 5 8-A12B 8-K 8-K/A ARS CERTNAS CORRESP D DEF 14A DEFA14A EFFECT NT 10-K NT 10-Q POS AM POS EX PRE 14A PRER14A RW S-1 S-1/A S-1MEF S-3 S-3/A S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
PRE 14A FORM PRE 14A 0001437749-26-004131 Feb 13, 2026 Mar 23, 2026
PRE 14A FORM PRE 14A 0001437749-24-027778 Aug 27, 2024 Oct 8, 2024
PRE 14A PRE 14A 0001104659-23-130502 Dec 29, 2023
PRE 14A PRE 14A 0001104659-22-129928 Dec 23, 2022 Feb 2, 2023
PRE 14A PRE 14A 0001654954-21-003039 Mar 22, 2021 Mar 19, 2021
PRE 14A PRIMARY DOCUMENT 0001654954-20-012931 Nov 25, 2020 Dec 18, 2020
PRE 14A PRELIMINARY PROXY STATEMENT 0001654954-20-007036 Jun 29, 2020 Jul 23, 2020
PRE 14A PRELIMINARY PROXY STATEMENT 0001654954-20-001997 Feb 27, 2020 Mar 23, 2020
PRE 14A PROXY STATEMENT 0001654954-19-012062 Oct 29, 2019 Nov 21, 2019
PRE 14A PRE14A 0001654954-19-008608 Jul 30, 2019
PRE 14A PRIMARY DOCUMENT 0001654954-19-004908 Apr 26, 2019